Authors/Disclosures
|
Christopher J. Kenney, MD, FAAN
|
Dr. Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Kenney has or had stock in Xenon Pharmaceuticals. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Kevin D. Vuong
|
No disclosure on file |
|
Ali Al-Zuhairy, MD, PhD
|
Dr. Al-Zuhairy has nothing to disclose. |
|
|
No disclosure on file |
|
Christine B. Hunter, RN, BSN
(PDCMDC)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Eric Lancaster, MD, PhD
(The University of Pennsylvania, Dept. of Neurology)
|
Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program. |
|
Joseph Jankovic, MD, FAAN
(Baylor College of Medicine)
|
Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie. |